Stocktoria
Fisher & Paykel Healthcare Corporation Limited FPH.NZ
NZ · New Zealand Exchange · XNZE · stock · Healthcare · website
Fisher & Paykel Healthcare Corporation Limited financials (annual)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | NZ$2.3B | NZ$1.3B | NZ$1.8B | NZ$1.6B |
| Gross profit | NZ$1.5B | NZ$530.2M | NZ$1.1B | NZ$945.9M |
| R&D expense | NZ$235.5M | NZ$226.9M | NZ$198.2M | NZ$174.3M |
| SG&A expense | NZ$598.2M | NZ$534.4M | NZ$492.8M | NZ$431.9M |
| Operating income | NZ$477.8M | -NZ$371.0M | NZ$254.4M | NZ$240.7M |
| Interest expense | NZ$10.3M | NZ$11.1M | NZ$18.2M | NZ$6.7M |
| Income tax | NZ$163.0M | NZ$126.1M | NZ$103.1M | NZ$77.7M |
| Net income | NZ$468.5M | NZ$377.2M | NZ$132.6M | NZ$250.3M |
| EPS (diluted) | NZ$0.79 | NZ$0.64 | NZ$0.23 | NZ$0.43 |
| Cash & equivalents | NZ$461.1M | NZ$264.5M | NZ$82.0M | NZ$121.0M |
| Inventory | NZ$327.3M | NZ$342.9M | NZ$320.4M | NZ$365.8M |
| Total assets | NZ$2.9B | NZ$2.6B | NZ$2.3B | NZ$2.2B |
| Total debt | NZ$146.1M | NZ$153.3M | NZ$189.1M | NZ$145.8M |
| Total liabilities | NZ$738.2M | NZ$660.4M | NZ$522.6M | NZ$451.1M |
| Shareholders' equity | NZ$2.1B | NZ$1.9B | NZ$1.8B | NZ$1.8B |
Growth · year-over-year · Revenue CAGR 13.3%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | +80.3% | -27.2% | +10.7% | — |
| Net income growth | +24.2% | +184.5% | -47.0% | — |
| EPS growth | +24.1% | +182.7% | -47.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · NZ · as of 2026-03-31. Figures in NZD. Facts plus Stocktoria's own computed scores — not investment advice.